Back Pain News and Research

Latest Back Pain News and Research

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Bristol-Myers Squibb Company today announced four-year data from the Phase 3 CheckMate -067 clinical trial - the longest follow-up to date - which continues to demonstrate durable, long-term survival benefits with the first-line combination of Opdivo (nivolumab) and Yervoy (ipilimumab), versus Yervoy alone, in patients with advanced melanoma.

22 Oct 2018

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.

22 Oct 2018

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis, a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may have another treatment option in the biologic drug ixekizumab.

22 Oct 2018

$11 million NIH grant for Clemson University helps launch new center for musculoskeletal research

With an $11 million grant from the National Institutes of Health Center for Biomedical Research Excellence, Clemson University has launched the South Carolina Center for Translational Research Improving Musculoskeletal Health, or SC-TRIMH, a new research center that will bring together scientists from across South Carolina to change the way musculoskeletal disorders are diagnosed, treated and even studied.

19 Oct 2018

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, product name in the United States: BELVIQ, product name for once-daily formulation in the United States: BELVIQ XR, "lorcaserin") in 17 countries in Latin America and the Caribbean, excluding Brazil, to Eurofarma Laboratorios S.A. which has a business foundation in Latin America.

16 Oct 2018

Simple procedure could be efficacious intervention for failed back surgery

Failed back surgery (continued low back and leg pain after surgery) is relatively common. With each reoperation, success, as defined by pain reduction, becomes less likely and most patients do not improve.

15 Oct 2018

$Thesis sheds new light on women with vertebral compression fractures$

Thesis sheds new light on women with vertebral compression fractures

Older women who suffer vertebral fractures rarely attract the attention of health care providers. A dissertation at Sahlgrenska Academy, Sweden, throws new light on a group of individuals with chronic pain as a constant companion.

9 Oct 2018

Survey: 2.5 million people experience back pain every day in the UK

One in five people who suffer from back pain have given up their job or reduced their hours because of their condition.

From medserena 9 Oct 2018

Health insurers have inconsistent policy terms for non-drug pain treatments, study finds

Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating lower back pain, a study led by researchers at Johns Hopkins Bloomberg School of Public Health has found.

6 Oct 2018

Microglia lead to increased neuro-inflammation in fibromyalgia patients, finds study

A study by Massachusetts General Hospital researchers - collaborating with a team at the Karolinska Institutet in Sweden - has documented for the first time widespread inflammation in the brains of patients with the poorly understood condition called fibromyalgia.

28 Sep 2018

Workers overdose on the job, and employers struggle to respond

Jimmy Sullivan prepared for his job as a bricklayer the same way every morning for years: injecting a shot of heroin before leaving his car.

28 Sep 2018

Mesoblast’s MPC therapy for children featured at symposium for congenital heart disease

Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.

26 Sep 2018

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum disorder.

24 Sep 2018

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.

21 Sep 2018

Home-based video game exercises can reduce chronic low back pain in older people, study finds

New research from University of Sydney has found home-based video-game exercises can reduce chronic low back pain in older people by 27 percent, which is comparable to benefits gained under programs supervised by a physiotherapist.

19 Sep 2018

Day-tripping to the dispensary: Seniors in pain hop aboard the canna-bus

Shirley Avedon, 90, had never been a cannabis user. But carpal tunnel syndrome that sends shooting pains into both of her hands and an aversion to conventional steroid and surgical treatments is prompting her to consider some new options.

18 Sep 2018

Sugar pills may help treat certain chronic pain patients

Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to new research.

12 Sep 2018

New evidence does not support use of invasive procedures for patients with chronic pain

An extensive review of 25 randomized clinical trials found "little evidence" that invasive surgery was more effective than sham or placebo procedures in reducing chronic pain. The study was published in the journal Pain Medicine.

12 Sep 2018

Back pain linked with mental health problems and risky behaviors in adolescents

A new study in the Journal of Public Health indicates that adolescents who experience back pain more frequently are also more likely to smoke cigarettes, drink alcohol, and report problems like anxiety and depression.

11 Sep 2018

Study raises concerns about inappropriate opioid prescribing, lax documentation practices

Nearly 30 percent of outpatient opioid prescriptions in the United States lack documented clinical reasons that justify the use of these potent drugs, according to a national analysis of physician visit records conducted by researchers at Harvard Medical School and the RAND Corporation.

11 Sep 2018

Back Pain News and Research

Latest Back Pain News and Research

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

$11 million NIH grant for Clemson University helps launch new center for musculoskeletal research

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Simple procedure could be efficacious intervention for failed back surgery

Thesis sheds new light on women with vertebral compression fractures

Survey: 2.5 million people experience back pain every day in the UK

Health insurers have inconsistent policy terms for non-drug pain treatments, study finds

Microglia lead to increased neuro-inflammation in fibromyalgia patients, finds study

Workers overdose on the job, and employers struggle to respond

Mesoblast’s MPC therapy for children featured at symposium for congenital heart disease

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

Home-based video game exercises can reduce chronic low back pain in older people, study finds

Day-tripping to the dispensary: Seniors in pain hop aboard the canna-bus

Sugar pills may help treat certain chronic pain patients

New evidence does not support use of invasive procedures for patients with chronic pain

Back pain linked with mental health problems and risky behaviors in adolescents

Study raises concerns about inappropriate opioid prescribing, lax documentation practices

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Back Pain News and Research

Latest Back Pain News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in